IMI

Intermolecular, Inc.
IMI

Delisted

IMI was delisted on the 19th of September, 2019.

40 hedge funds and large institutions have $35.5M invested in Intermolecular, Inc. in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more capital inflows, than outflows

Capital inflows: $13.5M | Capital outflows: $5.08M

150% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 8

43% more funds holding

Funds holding: 28 → 40 (+12)

14.74% more ownership

Funds ownership: 46.3% → 61.03% (+15%)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
40
Holders Change
+12
Holders Change %
+42.86%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
3
Reduced
5
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IMI Hedge Fund Activity: Q2 2019 in Review

40 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q2 2019, worth a combined $35.5M — up 34% from $26.5M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new IMI positions and 8 closed out — a net gain of 12 holders — while 3 added to existing stakes and 5 trimmed.

The largest buyer was Gardner Lewis Asset Management, opening a new position worth an estimated $5.25M. The largest seller was B. Riley Financial, exiting entirely with an estimated $2.8M sold.

  • 40 institutional investors held Intermolecular, Inc. (IMI) as of Q2 2019, up from 28 in Q1 2019.
  • Funds reported $35.5M of Intermolecular, Inc. stock for Q2 2019, up 34% quarter-over-quarter.
  • 20 funds opened new Intermolecular, Inc. positions in Q2 2019 and 8 closed out, a net change of +12 holders.
  • The largest Intermolecular, Inc. buyer in Q2 2019 was Gardner Lewis Asset Management, an estimated $5.25M added.
  • The largest Intermolecular, Inc. seller in Q2 2019 was B. Riley Financial, an estimated $2.8M sold.

Based on aggregated 13F filings for Q2 2019.